{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:52:50Z","timestamp":1791219170293,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203934"],"award-info":[{"award-number":["82203934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272356"],"award-info":[{"award-number":["82272356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Talent Introduction Project of Hubei Polytechnic University","award":["21xjz33R"],"award-info":[{"award-number":["21xjz33R"]}]},{"name":"the Talent Introduction Project of Hubei Polytechnic University","award":["21xjz34R"],"award-info":[{"award-number":["21xjz34R"]}]},{"name":"the Key research and development program of Yunnan Province","award":["202403AC100011"],"award-info":[{"award-number":["202403AC100011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10194-8","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:12:29Z","timestamp":1768338749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data"],"prefix":"10.1007","volume":"37","author":[{"given":"Rong-Jing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Wang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"11","key":"10194_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14(11):1083\u20131086","journal-title":"Nat Methods"},{"issue":"4","key":"10194_CR2","doi-asserted-by":"publisher","first-page":"e13434","DOI":"10.1111\/dth.13434","volume":"33","author":"P Amerio","year":"2020","unstructured":"Amerio P et al (2020) COVID-19 and psoriasis: should we fear for patients treated with biologics? Dermatol Ther 33(4):e13434","journal-title":"Dermatol Ther"},{"issue":"1","key":"10194_CR3","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1038\/s41467-019-11152-6","volume":"10","author":"KH Antunes","year":"2019","unstructured":"Antunes KH et al (2019) Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun 10(1):3273","journal-title":"Nat Commun"},{"issue":"5","key":"10194_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/ar2488","volume":"10","author":"SP Ardoin","year":"2008","unstructured":"Ardoin SP, Pisetsky DS (2008) Developments in the scientific Understanding of lupus. Arthritis Res Ther 10(5):218","journal-title":"Arthritis Res Ther"},{"key":"10194_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","volume":"83","author":"K Chen","year":"2017","unstructured":"Chen K, Liu J, Cao X (2017) Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun 83:1\u201311","journal-title":"J Autoimmun"},{"issue":"1","key":"10194_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/jdv.17635","volume":"36","author":"PR Criado","year":"2022","unstructured":"Criado PR et al (2022) COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria. J Eur Acad Dermatol Venereol 36(1):e1\u2013e3","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10194_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2022","unstructured":"Crow YJ, Stetson DB (2022) The type I interferonopathies: 10 years on. Nat Rev Immunol 22(8):471\u2013483","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10194_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/jid.2014.532","volume":"135","author":"AM D\u2019Erme","year":"2015","unstructured":"D\u2019Erme AM et al (2015) IL-36\u03b3 (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol 135(4):1025\u20131032","journal-title":"J Invest Dermatol"},{"key":"10194_CR9","doi-asserted-by":"publisher","first-page":"930866","DOI":"10.3389\/fimmu.2022.930866","volume":"13","author":"Z Dong","year":"2022","unstructured":"Dong Z et al (2022) Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data. Front Immunol 13:930866","journal-title":"Front Immunol"},{"issue":"3","key":"10194_CR10","first-page":"CD011571","volume":"3","author":"G Dupire","year":"2019","unstructured":"Dupire G et al (2019) Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 3(3):CD011571","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10194_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/09546634.2020.1789051","volume":"33","author":"A Ebrahimi","year":"2022","unstructured":"Ebrahimi A, Sayad B, Rahimi Z (2022) COVID-19 and psoriasis: biologic treatment and challenges. J Dermatolog Treat 33(2):699\u2013703","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10194_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti C, Bayry J (2020) Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 16(8):413\u2013414","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10194_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41419-021-03724-6","volume":"12","author":"Y Gao","year":"2021","unstructured":"Gao Y et al (2021) Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells. Cell Death Dis 12(5):450","journal-title":"Cell Death Dis"},{"issue":"9583","key":"10194_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370(9583):263\u2013271","journal-title":"Lancet"},{"issue":"10281","key":"10194_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM et al (2021) Psoriasis. Lancet 397(10281):1301\u20131315","journal-title":"Lancet"},{"key":"10194_CR16","doi-asserted-by":"publisher","first-page":"258430","DOI":"10.1155\/2015\/258430","volume":"2015","author":"AT Gunes","year":"2015","unstructured":"Gunes AT et al (2015) Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res 2015:258430","journal-title":"J Immunol Res"},{"issue":"1","key":"10194_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","volume":"6","author":"JC Hall","year":"2010","unstructured":"Hall JC, Rosen A (2010) Type i interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6(1):40\u201349","journal-title":"Nat Rev Rheumatol"},{"key":"10194_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v12060672","author":"W Hao","year":"2020","unstructured":"Hao W, Wang L, Li S (2020) FKBP5 regulates RIG-I-mediated NF-kappaB activation and influenza A virus infection. Viruses. https:\/\/doi.org\/10.3390\/v12060672","journal-title":"Viruses"},{"issue":"20","key":"10194_CR19","first-page":"6411","volume":"25","author":"RW Hu","year":"2021","unstructured":"Hu RW et al (2021) Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA. Eur Rev Med Pharmacol Sci 25(20):6411\u20136424","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10223","key":"10194_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"issue":"1","key":"10194_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2881","volume":"12","author":"GD Kalliolias","year":"2010","unstructured":"Kalliolias GD, Ivashkiv LB (2010) Overview of the biology of type I interferons. Arthritis Res Ther 12(1):S1","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10194_CR22","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","volume":"136","author":"J Kim","year":"2016","unstructured":"Kim J et al (2016) The spectrum of mild to severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes. J Invest Dermatol 136(11):2173\u20132182","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10194_CR23","first-page":"e632","volume":"35","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak L, Szepietowski JC (2021) Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol 35(10):e632\u2013e634","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10194_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2020.05.018","volume":"83","author":"Y Kuang","year":"2020","unstructured":"Kuang Y et al (2020) Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey. J Am Acad Dermatol 83(2):670\u2013672","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10194_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13509","volume":"33","author":"\u00d6 Kutlu","year":"2020","unstructured":"Kutlu \u00d6, Metin A (2020) Dermatological diseases presented before COVID-19: are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? Dermatol Ther 33(4):e13509","journal-title":"Dermatol Ther"},{"issue":"7","key":"10194_CR26","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/jid.2014.28","volume":"134","author":"B Li","year":"2014","unstructured":"Li B et al (2014) Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol 134(7):1828\u20131838","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10194_CR27","doi-asserted-by":"publisher","first-page":"e3000849","DOI":"10.1371\/journal.pbio.3000849","volume":"18","author":"NAP Lieberman","year":"2020","unstructured":"Lieberman NAP et al (2020) In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol 18(9):e3000849","journal-title":"PLoS Biol"},{"issue":"2","key":"10194_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q (2021) COVID-19 and autoimmune diseases. Curr Opin Rheumatol 33(2):155\u2013162","journal-title":"Curr Opin Rheumatol"},{"key":"10194_CR29","doi-asserted-by":"publisher","first-page":"971071","DOI":"10.3389\/fimmu.2022.971071","volume":"13","author":"YW Lu","year":"2022","unstructured":"Lu YW et al (2022) L36G is associated with cutaneous antiviral competence in psoriasis. Front Immunol 13:971071","journal-title":"Front Immunol"},{"issue":"2","key":"10194_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/15569527.2012.727936","volume":"32","author":"VC Macias","year":"2013","unstructured":"Macias VC, Cunha D (2013) Psoriasis triggered by tetanus-diphtheria vaccination. Cutan Ocul Toxicol 32(2):164\u2013165","journal-title":"Cutan Ocul Toxicol"},{"issue":"12","key":"10194_CR31","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.molcel.2021.04.008","volume":"81","author":"L Martin-Sancho","year":"2021","unstructured":"Martin-Sancho L et al (2021) Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell 81(12):2656\u20132668e8","journal-title":"Mol Cell"},{"issue":"2","key":"10194_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jdermsci.2017.11.010","volume":"89","author":"JL Melero","year":"2018","unstructured":"Melero JL et al (2018) Deciphering psoriasis. A bioinformatic approach. J Dermatol Sci 89(2):120\u2013126","journal-title":"J Dermatol Sci"},{"issue":"11","key":"10194_CR33","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1111\/jocd.14508","volume":"20","author":"R Miladi","year":"2021","unstructured":"Miladi R et al (2021) Pustular psoriasis flare-up in a patient with COVID-19. J Cosmet Dermatol 20(11):3364\u20133368","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"10194_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/09546634.2020.1764904","volume":"31","author":"S Nasiri","year":"2020","unstructured":"Nasiri S et al (2020) A challenging case of psoriasis flare-up after COVID-19 infection. J Dermatolog Treat 31(5):448\u2013449","journal-title":"J Dermatolog Treat"},{"issue":"9","key":"10194_CR35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid D et al (2020) Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol 21(9):1094\u20131106","journal-title":"Nat Immunol"},{"issue":"1","key":"10194_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cels.2020.10.003","volume":"12","author":"KA Overmyer","year":"2021","unstructured":"Overmyer KA et al (2021) Large-Scale Multi-omic analysis of COVID-19 severity. Cell Syst 12(1):23\u201340e7","journal-title":"Cell Syst"},{"issue":"4","key":"10194_CR37","doi-asserted-by":"publisher","first-page":"e13632","DOI":"10.1111\/dth.13632","volume":"33","author":"R Ozaras","year":"2020","unstructured":"Ozaras R et al (2020) Covid-19 and exacerbation of psoriasis. Dermatol Ther 33(4):e13632","journal-title":"Dermatol Ther"},{"key":"10194_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02167-20","author":"MB Phillips","year":"2021","unstructured":"Phillips MB et al (2021) Lymphatic type 1 interferon responses are critical for control of systemic reovirus dissemination. J Virol. https:\/\/doi.org\/10.1128\/JVI.02167-20","journal-title":"J Virol"},{"issue":"9","key":"10194_CR39","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.autrev.2017.07.001","volume":"16","author":"C Picard","year":"2017","unstructured":"Picard C, Belot A (2017) Does type-I interferon drive systemic autoimmunity? Autoimmun Rev 16(9):897\u2013902","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10194_CR40","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/jdv.13091","volume":"29","author":"RA Raposo","year":"2015","unstructured":"Raposo RA et al (2015) Antiviral gene expression in psoriasis. J Eur Acad Dermatol Venereol 29(10):1951\u20131957","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10194_CR41","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v079.c02","author":"MC Sachs","year":"2017","unstructured":"Sachs MC (2017) plotROC: a tool for plotting ROC curves. J Stat Softw. https:\/\/doi.org\/10.18637\/jss.v079.c02","journal-title":"J Stat Softw"},{"issue":"1","key":"10194_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","volume":"6","author":"JW Schoggins","year":"2019","unstructured":"Schoggins JW (2019) Interferon-stimulated genes: what do they all do? Annu Rev Virol 6(1):567\u2013584","journal-title":"Annu Rev Virol"},{"key":"10194_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jtos.2021.09.007","volume":"23","author":"S Singh","year":"2022","unstructured":"Singh S et al (2022) SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response. Ocul Surf 23:184\u2013194","journal-title":"Ocul Surf"},{"key":"10194_CR44","doi-asserted-by":"publisher","first-page":"154635","DOI":"10.1016\/j.cyto.2018.12.018","volume":"132","author":"B Skaug","year":"2020","unstructured":"Skaug B, Assassi S (2020) Type I interferon dysregulation in systemic sclerosis. Cytokine 132:154635","journal-title":"Cytokine"},{"issue":"12","key":"10194_CR45","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1111\/jdv.17582","volume":"35","author":"E Sotiriou","year":"2021","unstructured":"Sotiriou E et al (2021) Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre. J Eur Acad Dermatol Venereol 35(12):e857\u2013e859","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10194_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13054-020-03158-0","volume":"24","author":"A Stallmach","year":"2020","unstructured":"Stallmach A et al (2020) Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series. Crit Care 24(1):444","journal-title":"Crit Care"},{"issue":"8","key":"10194_CR47","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","volume":"138","author":"J Takeshita","year":"2018","unstructured":"Takeshita J et al (2018) Risk of serious Infection, opportunistic Infection, and herpes Zoster among patients with psoriasis in the united Kingdom. J Invest Dermatol 138(8):1726\u20131735","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10194_CR48","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","volume":"139","author":"LC Tsoi","year":"2019","unstructured":"Tsoi LC et al (2019) Atopic dermatitis is an IL-13-Dominant disease with greater molecular heterogeneity compared to psoriasis. J Invest Dermatol 139(7):1480\u20131489","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10194_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13075-017-1501-z","volume":"20","author":"MJ Wahadat","year":"2018","unstructured":"Wahadat MJ et al (2018) Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? Arthritis Res Ther 20(1):4","journal-title":"Arthritis Res Ther"},{"issue":"204","key":"10194_CR50","doi-asserted-by":"publisher","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","volume":"5","author":"K Wolk","year":"2013","unstructured":"Wolk K et al (2013) IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med 5(204):204ra129","journal-title":"Sci Transl Med"},{"key":"10194_CR51","unstructured":"Worldometer (2022) Covid-19 coronavirus pandemic.\u00a0https:\/\/www.worldometers.info\/coronavirus\/#countries"},{"issue":"3","key":"10194_CR52","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","volume":"53","author":"D Wu","year":"2020","unstructured":"Wu D, Yang XO (2020) TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib. J Microbiol Immunol Infect 53(3):368\u2013370","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10194_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40257-022-00721-z","volume":"23","author":"PC Wu","year":"2022","unstructured":"Wu PC et al (2022) New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review. Am J Clin Dermatol 23(6):775\u2013799","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10194_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s13671-017-0178-5","volume":"6","author":"D Yan","year":"2017","unstructured":"Yan D et al (2017) The role of the skin and gut Microbiome in psoriatic disease. Curr Dermatol Rep 6(2):94\u2013103","journal-title":"Curr Dermatol Rep"},{"issue":"1","key":"10194_CR55","first-page":"225","volume":"20","author":"YJ Zhang","year":"2019","unstructured":"Zhang YJ et al (2019) Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis. Mol Med Rep 20(1):225\u2013235","journal-title":"Mol Med Rep"},{"key":"10194_CR56","doi-asserted-by":"publisher","first-page":"733171","DOI":"10.3389\/fimmu.2021.733171","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C et al (2021) Transcriptional profiling and machine learning unveil a concordant biosignature of type I Interferon-Inducible host response across nasal swab and pulmonary tissue for COVID-19 diagnosis. Front Immunol 12:733171","journal-title":"Front Immunol"},{"key":"10194_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136955","author":"S Zhou","year":"2022","unstructured":"Zhou S, Yao Z (2022) Roles of infection in psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23136955","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10194_CR58","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou Z et al (2020) Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27(6):883\u2013890e2","journal-title":"Cell Host Microbe"},{"issue":"10224","key":"10194_CR59","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","volume":"395","author":"A Zumla","year":"2020","unstructured":"Zumla A et al (2020) Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet 395(10224):e35\u2013e36","journal-title":"Lancet"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10194-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:05:38Z","timestamp":1768381538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10194"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10194-8","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23"}}